Pineal and nonpineal supratentorial primitive neuroectodermal tumors.
Pineal region supratentorial primitive neuroectodermal tumors (SPNETs; pineoblastomas) and nonpineal SPNETs are rare tumors that historically have carried a very poor prognosis. With multimodality therapy, including maximal surgical resection, craniospinal radiation therapy and chemotherapy, the survival for patients with pineal PNETs has significantly improved. Chemotherapy alone, at least in conventional doses, appears to be insufficient treatment for younger children with pineoblastomas, in whom there is almost universal rapid tumor progression and death. Survival of patients with nonpineal SPNETs remains in the order of 30-35% despite multimodality therapy. Unlike those with pineal SPNETs, a significant percentage of infants with nonpineal SPNETs who undergo gross total surgical resection followed by chemotherapy will be long-term survivors. This article gives an overview of the natural history, prognostic factors and treatment of both pineal and nonpineal SPNETs.
Jakacki
R I
RI
Children's Hospital of Pittsburgh, 3520 Fifth Avenue, Suite 205, Pittsburgh, PA 15213, USA. jakackr@chplink.chp.edu
D002675:Child, Preschool; D003131:Combined Modality Therapy; D006801:Humans; D007223:Infant; D018242:Neuroectodermal Tumors, Primitive / Q000188:drug therapy / Q000628:therapy*; D010870:Pineal Gland; D011379:Prognosis; D015173:Supratentorial Neoplasms / Q000188:drug therapy / Q000628:therapy*